Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.

Hamam R, Hamam D, Alsaleh KA, Kassem M, Zaher W, Alfayez M, Aldahmash A, Alajez NM. · 2017

Read Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers. by Hamam R, Hamam D, Alsaleh KA, Kassem M, Zaher W, Alfayez M, Aldahmash A, Alajez NM. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5636984.txt.

Description

Hamam and co-authors review tiny RNA molecules in the blood as signs of breast cancer. Their review covers microRNAs that travel in the blood of patients. Such markers could aid early diagnosis and track how treatment works. The authors note that blood tests for these molecules are still hard to standardize.

The review explains how microRNAs form and how they silence genes. It weighs the strengths and limits of blood microRNAs as tests. The authors warn that many of these molecules come from normal body responses, not the tumor itself. Open questions cover disease specificity, sample handling, and how to normalize test results.

Catalog record

CREATORHamam R, Hamam D, Alsaleh KA, Kassem M, Zaher W, Alfayez M, Aldahmash A, Alajez NM.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE64 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5636984

Browse the full library · About the Tower of Babel